Cravit (TN) | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Cravit (TN)
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Cravit (TN)

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

82 API Suppliers, 27 USDMF, 11 JDMF, 3 EU WC, 21 KDMF, 21 NDC API, 28 Listed Suppliers, $ API Reference Price

82 API Suppliers
27 USDMF
11 JDMF
3 EU WC
21 KDMF
21 NDC API
28 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

48 Drugs in Development

48 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

555 FDF Dossiers, 119 FDA Orange Book, 217 Europe, 19 Canada, 42 South Africa, 158 Listed Dossiers

555 FDF Dossiers
119 FDA Orange Book
217 Europe
19 Canada
42 South Africa
158 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION/DROPS;OPHTHALMIC - 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION/DROPS;OPHTHALMIC - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 250MG/10ML

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION/DROPS;OPHTHALMIC - 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION/DROPS;OPHTHALMIC - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;ORAL - 250MG/10ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 4 SPI Pharma, 7 DKSH, 1 Pharm-RX Chemical, 9 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Kirsch Pharma, 1 ACG Worldwide, 15 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 24 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 4 Finar, 11 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 20 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

59 Fillers, Diluents & Binders, 43 Coating Systems & Additives, 39 Disintegrants & Superdisintegrants, 30 Solubilizers, 29 Thickeners and Stabilizers, 28 Direct Compression, 27 Granulation, 27 Parenteral, 22 Controlled & Modified Release, 20 Topical, 15 Lubricants & Glidants, 14 Film Formers & Plasticizers, 13 Co-Processed Excipients, 13 Taste Masking, 11 Chewable & Orodispersible Aids, 8 Emulsifying Agents, 7 Rheology Modifiers, 6 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

59 Fillers, Diluents & Binders
43 Coating Systems & Additives
39 Disintegrants & Superdisintegrants
30 Solubilizers
29 Thickeners and Stabilizers
28 Direct Compression
27 Granulation
27 Parenteral
22 Controlled & Modified Release
20 Topical
15 Lubricants & Glidants
14 Film Formers & Plasticizers
13 Co-Processed Excipients
13 Taste Masking
11 Chewable & Orodispersible Aids
8 Emulsifying Agents
7 Rheology Modifiers
6 API Stability Enhancers
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents

DIGITAL CONTENT

48 News #PharmaBuzz

48 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 221 Regulatory FDF Prices, 1 Annual Reports

19 US Medicaid Prescriptions
221 Regulatory FDF Prices
1 Annual Reports

MARKET PLACE

31 APIs, 34 FDF Dossiers, 1 Intermediates

31 APIs
34 FDF Dossiers
1 Intermediates

PATENTS & EXCLUSIVITIES

5 Health Canada Patents

5 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 13 Others

1 USP
13 Others

ANALYTICAL

1 BioAnalytical Methods, 2 Analytical Methods

1 BioAnalytical Methods
2 Analytical Methods

$ API Ref.Price (USD/KG) : 133 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 5Gowling WLG (Canada) LLP

filter Patent Reset all filters

5 All

01 12608273

02 12739893

03 12739897

04 12759874

05 12773033

filter Product Reset all filters

5 All

01 5LEVOFLOXACIN

filter Dosage Reset all filters

5 All

01 5SOLUTION

filter Exp Date Reset all filters

5 All

01 12026-05-18

02 22029-10-06

03 12030-04-22

04 12030-09-03

Product Main Page

01

Gowling WLG (Canada) LLP

Levofloxacin

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-10-06

Date Granted : 2016-10-04

Levofloxacin

Brand Name : QUINSAIR

Patent Number : 2739893

Filing Date : 2009-10-06

Strength per Unit : 100 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INHALATION

Patent Expiration Date : 2029-10-06

Date Granted : 2016-10-04

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling WLG (Canada) LLP

Levofloxacin

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-09-03

Date Granted : 2016-10-11

Levofloxacin

Brand Name : QUINSAIR

Patent Number : 2773033

Filing Date : 2010-09-03

Strength per Unit : 100 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INHALATION

Patent Expiration Date : 2030-09-03

Date Granted : 2016-10-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling WLG (Canada) LLP

Levofloxacin

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-05-18

Date Granted : 2015-10-20

Levofloxacin

Brand Name : QUINSAIR

Patent Number : 2608273

Filing Date : 2006-05-18

Strength per Unit : 100 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INHALATION

Patent Expiration Date : 2026-05-18

Date Granted : 2015-10-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling WLG (Canada) LLP

Levofloxacin

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-04-22

Date Granted : 2016-11-08

Levofloxacin

Brand Name : QUINSAIR

Patent Number : 2759874

Filing Date : 2010-04-22

Strength per Unit : 100 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INHALATION

Patent Expiration Date : 2030-04-22

Date Granted : 2016-11-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Gowling WLG (Canada) LLP

Levofloxacin

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-10-06

Date Granted : 2017-10-03

Levofloxacin

Brand Name : QUINSAIR

Patent Number : 2739897

Filing Date : 2009-10-06

Strength per Unit : 100 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INHALATION

Patent Expiration Date : 2029-10-06

Date Granted : 2017-10-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!